Gene: PGAM5
Official Full Name: PGAM family member 5, mitochondrial serine/threonine protein phosphataseprovided by VGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
GP00410 | PGAM5 gRNA1-gRNA2 KO plasmid | PGAM5 | $850 | |||
KO01287 | PGAM5 Knockout cell line(PK-15) | Pig | PGAM5 | 1:2-1:4 | Negative | Online Inquiry |
KO08350 | PGAM5 Knockout cell line (HeLa) | Human | PGAM5 | 1:3~1:6 | Negative | Online Inquiry |
KO08351 | PGAM5 Knockout cell line (HCT 116) | Human | PGAM5 | 1:2~1:4 | Negative | Online Inquiry |
KO08352 | PGAM5 Knockout cell line (HEK293) | Human | PGAM5 | 1:3~1:6 | Negative | Online Inquiry |
KO08353 | PGAM5 Knockout cell line (A549) | Human | PGAM5 | 1:3~1:4 | Negative | Online Inquiry |
PGAM5 Gene Knockout Cell Lines are genetically modified cell lines in which the PGAM5 gene has been selectively inactivated. PGAM5 (Phosphoglycerate Mutase 5) serves key roles in cellular metabolism and signaling, particularly in the regulation of mitochondrial function and apoptosis. By using these knockout cell lines, researchers can investigate the downstream effects of PGAM5 deficiency, facilitating a deeper understanding of its role in various biological processes and diseases.
The primary function of PGAM5 is to catalyze the interconversion of phosphoglycerate forms, influencing multiple metabolic pathways that affect energy production and cell survival. By studying these knockout models, scientists can elucidate the molecular mechanisms underlying mitochondrial dysfunction and deregulated cell death, which are implicated in numerous pathologies including neurodegenerative diseases and cancer. This product enables high-throughput screening and targeted investigations in both fundamental and applied research settings.
When compared to traditional cell lines, PGAM5 Gene Knockout Cell Lines offer distinct advantages. They allow precise elucidation of gene function and eliminate confounding factors associated with gene expression variability. Moreover, having a reliable model of PGAM5 deficiency accelerates research timelines, significantly enhances reproducibility, and paves the way for potential therapeutic targets.
Researchers and clinicians seeking to develop novel strategies for intervention in PGAM5-related pathways will find these knockout cell lines invaluable. Whether it’s for basic research or drug discovery, the high fidelity of these models provides critical insights that can lead to groundbreaking advancements.
Our company prides itself on being at the forefront of molecular biology tools, backed by rigorous quality control and scientific expertise. We are committed to supporting the research community with innovative products that empower discovery and lead to significant clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.